Mesenteric approach for borderline resectable pancreatic head cancer: a 13-Year retrospective cohort study.

Langenbecks Arch Surg · 2025 · PMC12397144 · PMID 40879829

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although this difference did not reach statistical significance, when combined with the analysis of discontinuation reasons, the mesenteric approach group showed significantly fewer treatment interruptions due to disease progression (12.5% vs. 26.9%, χ2=4.13, P = 0.042).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.